Nyxoah (NASDAQ:NYXH) Price Target Cut to $15.00 by Analysts at HC Wainwright

Nyxoah (NASDAQ:NYXH) had its target price cut by HC Wainwright from $17.00 to $15.00 in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.

Separately, Stifel Nicolaus dropped their target price on Nyxoah from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, March 14th.

Nyxoah Trading Down 21.4 %

Shares of Nyxoah stock opened at $8.91 on Wednesday. The firm’s 50 day moving average is $10.47 and its 200 day moving average is $9.35. The firm has a market capitalization of $303.47 million, a PE ratio of -4.76 and a beta of 1.42. Nyxoah has a 1 year low of $6.76 and a 1 year high of $14.20. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21.

Nyxoah (NASDAQ:NYXH) last posted its earnings results on Thursday, March 13th. The company reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Nyxoah had a negative return on equity of 51.68% and a negative net margin of 1,043.93%. The company had revenue of $1.35 million for the quarter, compared to the consensus estimate of $2.02 million. Equities research analysts forecast that Nyxoah will post -1.91 earnings per share for the current fiscal year.

Institutional Trading of Nyxoah

A number of institutional investors and hedge funds have recently bought and sold shares of NYXH. Kovack Advisors Inc. increased its stake in shares of Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock valued at $160,000 after buying an additional 10,000 shares during the period. LPL Financial LLC bought a new position in shares of Nyxoah in the 4th quarter worth about $102,000. Geode Capital Management LLC lifted its stake in Nyxoah by 19.4% in the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after buying an additional 2,774 shares during the period. Renaissance Technologies LLC bought a new stake in shares of Nyxoah in the 4th quarter valued at $187,000. Finally, Walleye Capital LLC grew its holdings in Nyxoah by 23.9% in the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock worth $119,000 after purchasing an additional 2,862 shares during the period.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.